Shares of InMode Ltd. (INMD) touched an all-time high of $84.70 in intraday trading on Monday, before closing at $82.78.
InMode develops devices that use minimally invasive radio-frequency technology for aesthetic medical procedures such as contouring, skin treatment, acne, hair removal, anti-aging, women's health & wellness, pigment, and vascular issues.
On Sep.10, 2019, just a month after its IPO, we had alerted readers to this stock when it was trading around $25 (Report titled "InMode in Steady Mode"). By the end of that year, the stock price had almost doubled, thanks to the company's improving revenue and net income, driven by growing demand for its products in the United States and abroad (Report titled "Healthcare IPOs That Delivered Solid Returns In 2019, dated Dec.12, 2019).
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.